Developing dosing guidance for new and upcoming formulations of paediatric ARVs in line with Treatment 2.0 priorities
Report of the meeting of the Antiretroviral Working Group (25-26 October 2011)
Overview
As access to paediatric antiretroviral (ARV) treatment expands worldwide, there is an increasing need to improve and simplify formulations for children. In moving towards the joint UNAIDS/WHO Treatment 2.0 initiative, revised dosing guidance for new and current paediatric formulations will be critical to ensuring children have access to better, safer and simpler treatment.